Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms

Alexion to Buy Achillion in $930M Marriage of Rare Disease Drug Firms

Source: 
Xconomy
snippet: 

Alexion Pharmaceuticals is acquiring Achillion Pharmaceuticals for $930 million, a deal that could strengthen its position providing treatments for a rare blood disorder.